![GP000045: MUC1(126-149-Cys)-STn(131,144) Pack Size:1 mg Galα(1-3)[Fucα(1-2)]Gal-β-O-(CH2)8-C(O)NH-(CH2)2-NH-biotin](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/GP000005_9528dc09-8f2b-42f4-812a-ddd6f6402804.svg?v=1731437119)
Pay in 4 interest-free payments of $87.50 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Galα(1-3)[Fucα(1-2)]Gal-β-O-(CH2)8-C(O)NH-(CH2)2-NH-biotin
which keep the glycan inert during synthesis and are removed under mild base (e
/ Fmoc-Thr(Man(Ac)4-α-D)-OH / Fmoc-Thr(α-D-Man)-OH (Peracetate)
the innermost N-glycan residue with the α1-6 core fucose that modulates antibody effector function and is a focus of biopharmaceutical glycoengineering
/ HHV1-gB(53-56)-STn(53) / HHV1P
GP000045: MUC1(126-149-Cys)-STn(131,144) Pack Size:1 mg Galα(1-3)[Fucα(1-2)]Gal-β-O-(CH2)8-C(O)NH-(CH2)2-NH-biotinC136H214N34O59S 3301. 41 Synthetic glycopeptide. Glycosylated Mucin 1 (MUC1) peptide fragment containing amino acid sequence Pro126Gly149 (24 AA in length) from the tandem repeat (TR) region of the MUC1 protein. Tumour associated cancer antigen, sialyl Tn (STn) antigen, O glycosylation (NeuAc2 6GalNAc) at Thr131 and Thr144. The C terminus Cysteine (thiol) allows for conjugation to maleimide functionalized carrier proteins. MUC1(126 149 Cys)
